We are live on ! Find out more
VTAK icon

Catheter Precision

5 hedge funds and large institutions have $3.27M invested in Catheter Precision in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

29% less funds holding

Funds holding: 75 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

68% less capital invested

Capital invested by funds: $10.2M → $3.27M (-$6.94M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q3 2019 in Review

5 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2019, worth a combined $3.27M — down 68% from $10.2M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VTAK and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Vanguard Group, opening a new position worth an estimated $540K. The largest seller was Franklin Resources, exiting entirely with an estimated $832K sold.

  • 5 institutional investors held Catheter Precision (VTAK) as of Q3 2019, down from 7 in Q2 2019.
  • Funds reported $3.27M of Catheter Precision stock for Q3 2019, down 68% quarter-over-quarter.
  • 1 fund opened new Catheter Precision positions in Q3 2019 and 3 closed out, a net change of -2 holders.
  • The largest Catheter Precision buyer in Q3 2019 was Vanguard Group, an estimated $540K added.
  • The largest Catheter Precision seller in Q3 2019 was Franklin Resources, an estimated $832K sold.

Based on aggregated 13F filings for Q3 2019.